Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Hematopoietic stem-cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood, in order to replicate inside a patient and produce additional normal blood cells. HSCT may be autologous (the patient's own stem cells are used), syngeneic (stem cells…
History, Applications & Research
Explore the main themes, entities and connections around Hematopoietic stem cell transplantation. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
cells hsct patients transplant blood allogeneic disease donor marrow bone stem treatment may transplantation donors graft-versus-host also patient autologous transplants
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Hematopoietic stem cell transplantation | ICD-9-CM | 41.0 | 1.00 | infobox |
| Hematopoietic stem cell transplantation | MedlinePlus | 003009 | 1.00 | infobox |
| Hematopoietic stem cell transplantation | MeSH | D018380 | 1.00 | infobox |
| severe combined immunodeficiency or congenital neutropenia with defective stem cells | instance of | Candidates for HSCTs include pediatric cases where the patient has an inborn defect | 0.80 | text |
| and also children or adults with aplastic anemia who have lost their stem cells after birth | instance of | Candidates for HSCTs include pediatric cases where the patient has an inborn defect | 0.80 | text |
| acute myeloid leukemia | instance of | These advantages have established autologous HSCT as one of the standard second-line treatments for such diseases as lymphoma.For other cancers | 0.80 | text |
| though | instance of | These advantages have established autologous HSCT as one of the standard second-line treatments for such diseases as lymphoma.For other cancers | 0.80 | text |
| the reduced mortality of the autogenous relative to allogeneic HSCT may be outweighed by an increased likelihood of cancer relapse | instance of | These advantages have established autologous HSCT as one of the standard second-line treatments for such diseases as lymphoma.For other cancers | 0.80 | text |
| related mortality | instance of | These advantages have established autologous HSCT as one of the standard second-line treatments for such diseases as lymphoma.For other cancers | 0.80 | text |
| so the allogeneic treatment may be preferred for those conditions.Autologous HSCT is also used as a treatment option for specific autoimmune conditions | instance of | These advantages have established autologous HSCT as one of the standard second-line treatments for such diseases as lymphoma.For other cancers | 0.80 | text |
| a parent | instance of | a half-matched relative | 0.80 | text |
| child | instance of | a half-matched relative | 0.80 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.